[1] COLE S P C, BHANDWAJ G, GERLACH J H. Overexpression of a transporter gene in a multidrug-resistance human lung cancer cell line. 1992(4). doi:10.1126/science.1360704
[2] ENDO K, MAEHARA Y, KUSUMOTO T. 3.0.CO, 2-A.aspx">Expression of multidrug-resistance-associated protein (MRP) and chemsensitivity in human gastric cancer. 1996(4). doi:10.1002/(SICI)1097-0215(19961104)68:3<, 372::AID-IJC16>, 3.0.CO, 2-A
[3] TAKEBAYASHI Y, AKIYAMA S, NATSUGOE S. The expression of multidrug resistance protein in human gastrointestinal tract carcinoma, 2002(4)
[4] SAKAMOTO H, YONEZAWA S, UTSUNOMIYA T. Mutin antigen expression in gastric carcinomas of young and old adults. 1997(9). doi:10.1016/S0046-8177(97)90059-9
[5] SCHEPER R J, BROXTERMAN H J, SCHETTER G L. Overexpression of a Mr 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance, 1993(7)
[6] SCHEFFER G L, WIJINGARD P L G, FLENS M J. The drug resistance-related protein (LRP) is the vault protein. 1995(6). doi:10.1038/nm0695-578
[7] IKEDA K, OKAM, NARASAKI F. Lung resistance-related protein gene expression and drug sensitivity in human gastric and lung cancer cells, 2003(40)
[8] KUNZE N, YAANG G C, DOLBERG M. Structure of the human typeⅠ DNA topoisomerase gene, 1991(15)
[9] SON Y S, SUH J M, AHN S H. Reduced activity of topoisomeraseⅡ in an Adriamycin-resistance human stomach-adenocarcinoma cell line. 1998(5). doi:10.1007/s002800050751
[10] KELLNER U, HUTCHINSON L, SEIDEL A. Decreased drug accumulation in a mitoxantrone-resistant gastric carcinoma cell line in the absence of P-glycoprotein. 2001(5)
[11] KIM P, OHI Y, INOUE H. Expression and relationship between topoisomeraseⅠ and Ⅱ alpha genes in tumor and nomal tissures in esophageal,gastric and colon cancer, 2003(68)
[12] STAHL M, KASIMIR BAUER S, HARSTRICK A. Down-regulation of topoisomeraseⅡ by camptothecin does not prevent additive activity of the topoisomeraseⅡ inhibitor etoposide in vitro, 1997(7)
[13] DANIEL V. Glutathione S-transferases:gene structure and regulation of expression. 1993(3). doi:10.3109/10409239309086794
[14] D'INCALCI M, BONFANTI M, PITTERI A. The antitumer activity of alkylating agents is not correlated with the levels of glatathione,glutathione transferase and O6-alkylguanine-DNA-alkyltransferase of human tumor xenografts, 2003(11)
[15] MONDEN M, AKE S, SUTOH I. Prognostic significance of the expressions of metallothionein,glutathione-S-transferase-pi,and P-glycoprotein in curatively resected gastric cancer, 2003(5)
[16] SCHIPPER D L, WAGENMANS M J, van HAELST U. Immunohistochemical determination of glutathione S-transferases in gastric carcinoma and in adjacent nomal gastric epithelium, 2002(2)
[17] AZZI A, BOSCOBOINIK D, HENSEY C. The protein kinase C family. 1992(3). doi:10.1111/j.1432-1033.1992.tb17219.x
[18] BECK J, BOHNER B, BRGER D. Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers,and correlation of PKC eta with MDR1,MRP and LRP gene expression, 1998(1)
[19] BUDWORTH J, GENT T W, GESCHER A. Co-ordinate loss of protein kinase C and multidrug resistance gene expression in revertant MCF-7/Adr breast carcinoma cells, 1997(9)
[20] 王向阳, 柳惠果. 表达反义蛋白激酶Cα提高人肺癌LTEPa-2细胞对抗肿瘤药物的敏感性, 1998(3)
[21] SCHWARTZ G K, HAIMOVITZ-FRIEDMAN A, DHUPAR S K. Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safinggol in mitomycin C-treated gastric cancer cells, 2002(18)
[22] GOODFELLOW H K, SARDINI A, RUETZ S. Protein Kinase C-mediated phosphorylation does not regulate drug transport by the human multidrug resistance P-glycoprotein, 2004(23) |
